Please login to the form below

Not currently logged in

Excellence in Pre-Commercialisation Communications

Sponsored by:


2020 Finalists


by Bedrock Healthcare Communications for Hansa Biopharma

For any patient with end-stage kidney disease (ESKD), waiting for a donor kidney is a lengthy, draining and stressful process, adding to the mental and physical burden of the disease and dependency upon dialysis. For those patients who are ’highly sensitised’, and immunologically incompatible with most potential donors, ensuring a state of ‘transplant-readiness’ is even more challenging.

Hansa Biopharma is in the pre-commercialisation phase of a therapy that it is hoped will increase transplant eligibility among this highly sensitised population. Recognising an unmet need for comprehensive support for all ESKD patients through the renal transplantation journey, Hansa commissioned the trans*PLAN programme. This global, multilingual initiative provides a virtual Transplant Community Centre supported by a behavioural change programme, designed to enable patients to access a range of instructive, life-enhancing resources and take control of their own transplant journey.

We describe the developmental stage of trans*PLAN, representing a collaborative effort between Bedrock Healthcare Communications, Sprout Behaviour Change, Syneos Health and Backpack Health. A combination of international market research, analysis of published literature, beta testing of hosting technology and engagement of patient associations has supported the design of the trans*PLAN programme and laid the foundations for its implementation.

Keeping Maturation on Track. Raising Awareness of Erythroid Maturation Defect in Europe and Canada

by MediTech Media (a part of Nucleus Global) for Celgene

Ineffective erythropoiesis (IE) is the underlying cause of chronic anaemia in several haematological disorders including myelodysplastic syndromes (MDS), thalassaemia, aplastic anaemia and sickle cell anaemia. Erythroid maturation defect (EMD) is a type of IE and patients experiencing EMD- associated anaemia have poorer prognoses, reduced survival and lower quality of life as they often require regular blood transfusions.

This integrated educational campaign raised awareness and understanding of EMD, helping HCPs understand the molecular mechanisms underlying the pathophysiology, enabling them to make informed decisions about new treatments that are in development.

Utilising a ‘Keep maturation on track’ creative, the campaign was launched at EHA 2019 and included innovative disease awareness tactics to educate HCPs about EMD, comprising an immersive augmented reality (AR) installation with 3D-printed cells representing the stages of red blood cell production. The analogy of a malfunctioning conveyor belt helped explain the key campaign messages. A flipper-book giveaway provided an enduring educational resource. Additional insightful and impactful campaign elements, including an educational website and paid media campaign, delivered consistent messaging and extended campaign reach.

The campaign provided impressive outcomes versus objectives, exceeding industry benchmarks, and gained fantastic target audience feedback, paving the way for HCPs to make more informed treatment decisions.

Executive summaries as submitted.

Back to full list

Category Sponsors

Catherine Devaney, WE Communications – Communiqué Awards Judge

Key dates

Entry deadline 11 March 2022
Extended entry deadline 18 March 2022
(additional fee applies)
Judging days May 2022
Awards Ceremony 7th July 2022

Contact information:

For sponsorship opportunities:
Sales Team
Tel: +44 (0)1372 414200

General event enquiries:
Debbie Tuesley
Tel: +44 (0)1372 414243

Entry and dinner booking enquiries:
Saoirse Meenaghan
Tel: 01372 414253